APC anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_APC_091809
C57BL/6 bone marrow cells stained with 1A8 APC
  • 1A8_APC_091809
    C57BL/6 bone marrow cells stained with 1A8 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
127613 25 µg 71€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127614 100 µg 252€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Patras KA, et al. 2019. J Innate Immun. :1. PubMed
  2. Yu‐Han Chang et al. 2017. Immunity. 47(5):943-958 . PubMed
  3. Li A, et al. 2020. Oncol Lett. 1.899305556. PubMed
  4. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  5. Ding Z, et al. 2021. Int J Mol Sci. 22:. PubMed
  6. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  7. Herisson F, et al. 2018. Nat Neurosci. 21:1209. PubMed
  8. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
  9. Stein K, et al. 2016. J Leukoc Biol. 99: 231 - 239. PubMed
  10. Christian D, et al. 2014. Infect Immun . 82:4056. PubMed
  11. Sharma A, et al. 2014. J Infect Dis. . PubMed
  12. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  13. Poli V, et al. 2021. iScience. 24:103256. PubMed
  14. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  15. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  16. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  17. Weiss M, et al. 2015. Proc Natl Acad Sci U S A. 112: 11001-11006. PubMed
  18. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  19. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  20. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  21. Han J, et al. 2022. FEBS J. 289:417. PubMed
  22. Shani O, et al. 2020. Cancer Res. 80:5317. PubMed
  23. Cheng G, et al. 2021. iScience. 24:102673. PubMed
  24. Meng L, et al. 2021. Front Oncol. 11:691705. PubMed
  25. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  26. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
  27. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
  28. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  29. Patnode M, et al. 2014. J Exp Med. 211:1281. PubMed
  30. Liao H, et al. 2015. Rheumatology. 54: 1317 - 1326. PubMed
  31. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  32. Thompson ER, et al. 2020. Am J Transplant. . PubMed
  33. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  34. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  35. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  36. Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed
  37. Yao ME, et al. 2022. Evid Based Complement Alternat Med. 2022:7784148. PubMed
  38. Pawaria S, et al. 2020. Arthritis Rheumatol. 72:359. PubMed
  39. Schlegel M, et al. 2018. J Clin Invest. 128:4711. PubMed
  40. Parlet CP, et al. 2019. Cell Rep. 27:187. PubMed
  41. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  42. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  43. Mooney J, et al. 2015. Sci Rep. 5: 14603. PubMed
  44. Ma Y, et al. 2016. Cardiovasc Res. 110: 51 - 61. PubMed
  45. Karmakar M, et al. 2016. Nat Commun. 7:10555. PubMed
  46. Chu C, et al. 2016. Dis Model Mech. 9: 473-481. PubMed
  47. Liu M, et al. 2020. Cell Rep. 32:107990. PubMed
  48. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  49. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  50. Goldman E, et al. 2021. Cells. 10:. PubMed
  51. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  52. Pan YC, et al. 2021. Mol Ther Oncolytics. 20:175. PubMed
  53. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  54. Michael BD, et al. 2020. Cell Reports. 32(11):108150. PubMed
  55. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  56. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  57. Horn KJ, et al. 2022. Nat Commun. 13:3321. PubMed
  58. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  59. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  60. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  61. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  62. Körner A, et al. 2019. Nat Commun. 10:633. PubMed
  63. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  64. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  65. Wang W, et al. 2020. Immunity. 51(6):1102-1118.e7.. PubMed
  66. Gottfried-Blackmore A, et al. 2009. Proc Natl Acad Sci U S A. 106:20918. PubMed
  67. Cui C, et al. 2021. Cell. 184(12):3163-3177.e21. PubMed
  68. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  69. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  70. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  71. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  72. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  73. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  74. Wang D, et al. 2021. Nat Commun. 12:2674. PubMed
  75. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  76. Körner A, et al. 2019. Proc Natl Acad Sci U S A. 116:20623. PubMed
  77. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
  78. Wang SS et al. 2018. Cell chemical biology. 25(12):1519-1532 . PubMed
  79. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  80. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  81. Zhou Q, et al. 2014. J Immunol. 193:496. PubMed
  82. Cho K, et al. 2021. iScience. 24:103117. PubMed
  83. Gurusamy M, et al. 2021. Nat Commun. 12:6798. PubMed
  84. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  85. Machácek T, et al. 2022. PLoS Pathog. 18:e1010302. PubMed
  86. Xiao Y, et al. 2022. Dis Markers. 2022:1380560. PubMed
  87. Bolkhovitina EL, et al. 2022. Int J Mol Sci. 23:. PubMed
  88. Monteran L, et al. 2022. Nat Commun. 13:5797. PubMed
  89. Li H, et al. 2019. Front Immunol. 2.205555556. PubMed
  90. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  91. Price P, et al. 2015. J Immunol. 194:1164. PubMed
  92. Albarrán-Juárez J, et al. 2016. Atherosclerosis. 251:445-53. PubMed
  93. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  94. Fraccarollo D, et al. 2021. eLife. 0.416666666666667. PubMed
  95. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  96. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  97. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  98. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  99. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  100. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  101. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  102. Smith CA, et al. 2019. JCI Insight. 4. PubMed
  103. Steichen A, et al. 2015. PLoS One. 10:123573. PubMed
  104. Cohen M, et al. 2014. EMBO J. 33:2906. PubMed
  105. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  106. Namiguchi K, et al. 2022. Front Cardiovasc Med. 8:761591. PubMed
  107. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  108. Peñaloza HF, et al. 2018. Biochem Biophys Rep. 13:12. PubMed
  109. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
  110. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  111. Patankar Y, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L902 - L913. PubMed
  112. Ioannidis L, et al. 2016. J Immunol. 196: 1227 - 1238. PubMed
  113. Wang SS, et al. 2021. Cell Chemical Biology. 28(5):699-710.e5. PubMed
  114. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  115. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  116. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  117. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  118. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  119. Bitschar K, et al. 2019. Nat Commun. 10:2730. PubMed
  120. Wingrove E et al. 2019. Cell reports. 27(4):1277-1292 . PubMed
  121. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  122. Ohno-Urabe S, et al. 2018. J Am Heart Assoc. 7:e007389. PubMed
  123. Resende M, et al. 2019. J Immunol. 203:2451. PubMed
  124. Salvagno C, et al. 2019. Nat Cell Biol. 1.229861111. PubMed
  125. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
  126. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  127. Kwon MY, et al. 2021. J Leukoc Biol. 110:711. PubMed
  128. Skokowa J, et al. 2022. Nat Commun. 13:2948. PubMed
  129. Lin T, et al. 2021. PLoS Pathog. 17:e1009557. PubMed
  130. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  131. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  132. Chua Y, et al. 2016. J Immunol. 197: 3771 - 3781. PubMed
  133. Ulrich V, et al. 2016. EMBO Mol Med. 8: 643 - 653. PubMed
  134. Molgora M, et al. 2020. Cell. 182:886. PubMed
  135. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  136. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  137. Shi J, et al. 2022. Front Pharmacol. 12:818326. PubMed
  138. Gautam S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. 319:L661. PubMed
  139. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  140. Kamei A, et al. 2012. J Infect Dis. 207:39. PubMed
  141. Gardner P, et al. 2015. Am J Pathol. 185:1324. PubMed
  142. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  143. Knuplez E, et al. 2021. British Journal of Pharmacology. 178(5):1234-1248. PubMed
  144. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  145. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  146. Asahara M, et al. 2022. PLoS One. 17:e0276135. PubMed
  147. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  148. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  149. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
  150. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
  151. Siolas D, et al. 2021. Cell Reports. 36(8):109578. PubMed
  152. Wang M, et al. 2021. iScience. 24(7):102766. PubMed
  153. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  154. Heuslein J, et al. 2016. Sci Rep. 6: 27029. PubMed
  155. Phadke MS, et al. 2021. Cancer Immunol Res. 9:554. PubMed
  156. Weng JH, et al. 2021. Nat Metab. 3:513. PubMed
  157. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  158. Zhang J et al. 2019. Cell Rep. 27(9):2679-2689 . PubMed
  159. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  160. Oertli M, et al. 2011. J Immunol. 187:3578. PubMed
  161. Cardoso M, et al. 2015. Infect Immun . 83: 3534-3544. PubMed
  162. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  163. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  164. Wang S, et al. 2022. Blood. 140:171. PubMed
  165. Liao YC, et al. 2021. Front Immunol. 12:743030. PubMed
  166. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  167. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  168. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  169. Young K, et al. 2021. Cell Stem Cell. . PubMed
  170. Cardoso F, et al. 2015. PLoS One. 10: 0131904. PubMed
  171. Devi S, et al. 2013. J Exp Med. 210:2321. PubMed
RRID
AB_1877163 (BioLegend Cat. No. 127613)
AB_2227348 (BioLegend Cat. No. 127614)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F
Purified anti-mouse Ly-6G 1A8 FC, IHC-F, IHC
Biotin anti-mouse Ly-6G 1A8 FC, IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC, IHC-F
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC, IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC, IHC-F, SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC, IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC, Depletion, IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC, CyTOF®, WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Go To Top Version: 3    Revision Date: 01.06.2017

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Alexa Fluor® 594 anti-mouse Ly-6G

  • Purified anti-mouse Ly-6G

  • Biotin anti-mouse Ly-6G

  • FITC anti-mouse Ly-6G

  • PE anti-mouse Ly-6G

  • Alexa Fluor® 647 anti-mouse Ly-6G

  • Pacific Blue™ anti-mouse Ly-6G

  • APC anti-mouse Ly-6G

  • PerCP/Cyanine5.5 anti-mouse Ly-6G

  • PE/Cyanine7 anti-mouse Ly-6G

  • Alexa Fluor® 700 anti-mouse Ly-6G

  • APC/Cyanine7 anti-mouse Ly-6G

  • Alexa Fluor® 488 anti-mouse Ly-6G

  • Brilliant Violet 421™ anti-mouse Ly-6G

  • Brilliant Violet 570™ anti-mouse Ly-6G

  • Ultra-LEAF™ Purified anti-mouse Ly-6G

  • Brilliant Violet 510™ anti-mouse Ly-6G

  • Purified anti-mouse Ly-6G (Maxpar® Ready)

  • Brilliant Violet 650™ anti-mouse Ly-6G

  • Brilliant Violet 711™ anti-mouse Ly-6G

  • Brilliant Violet 605™ anti-mouse Ly-6G

  • Brilliant Violet 785™ anti-mouse Ly-6G

  • PE/Dazzle™ 594 anti-mouse Ly-6G

  • APC/Fire™ 750 anti-mouse Ly-6G

  • PerCP anti-mouse Ly-6G

  • TotalSeq™-A0015 anti-mouse Ly-6G

  • TotalSeq™-C0015 anti-mouse Ly-6G

  • TotalSeq™-B0015 anti-mouse Ly-6G

  • Spark Blue™ 550 anti-mouse Ly-6G

  • Spark NIR™ 685 anti-mouse Ly-6G

  • Spark YG™ 593 anti-mouse Ly-6G

  • APC/Fire™ 810 anti-mouse Ly-6G Antibody

  • PE/Cyanine5 anti-mouse Ly-6G

  • PE/Fire™ 810 anti-mouse Ly-6G Antibody

  • Spark UV™ 387 anti-mouse Ly-6G

  • PE/Fire™ 640 anti-mouse Ly-6G

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account